Search Prime Grants

W81XWH2211054

Project Grant

Overview

Grant Description
A Prospective Observational Study on Therapeutic and Adverse Effects of Medical Cannabis for Chronic Traumatic Brain Injury
Awardee
Lovelace Biomedical Research Institute
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding Agency
U.S. Army Medical Research Acquisition Activity (USAMRAA) [DoD - USA - MEDCOM - MRDC]
Funding Agency
Medical Command (MEDCOM) [DoD - USA]
Place of Performance
Albuquerque, New Mexico 871085129 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH21TBIPHRPTRA
Lovelace Biomedical Research Institute was awarded Project Grant W81XWH2211054 worth $1,499,922 from Medical Command in September 2022 with work to be completed primarily in Albuquerque New Mexico United States. The grant has a duration of 4 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 9/21/22

Period of Performance
9/15/22
Start Date
9/14/26
End Date
40.0% Complete

Funding Split
$1.5M
Federal Obligation
$0.0
Non-Federal Obligation
$1.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2211054

Additional Detail

Award ID FAIN
W81XWH2211054
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit Without 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
W91ZSQ W03J HQ CO USA MED DEV MAT CM
Awardee UEI
MBT9RXJJ7428
Awardee CAGE
3MMH4
Performance District
01
Senators
Martin Heinrich
Ben Luján
Representative
Melanie Stansbury

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $1,499,922 100%
Modified: 9/21/22